Drug Shortage Report for SANDOZ DUTASTERIDE
Report ID | 10295 |
Drug Identification Number | 02424444 |
Brand name | SANDOZ DUTASTERIDE CAPSULE |
Common or Proper name | SANDOZ DUTASTERIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | |
Active Ingredient(s) | DUTASTERIDE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | G04CB |
ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-05-12 |
Actual start date | |
Estimated end date | 2017-06-26 |
Actual end date | 2017-08-18 |
Shortage status | Resolved |
Updated date | 2017-10-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-10-25 | French | Compare |
v3 | 2017-10-25 | English | Compare |
v2 | 2017-05-15 | French | Compare |
v1 | 2017-05-15 | English | Compare |
Showing 1 to 4 of 4